Latest On Mirati Therapeutics, Inc (MRTX):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-25 23:40 EST | News | Mirati tumbles after study failure for cancer drug; Oppenheimer upgrades | N/A |  |
| 2023-05-24 19:31 EST | News | Mirati lung cancer candidate sitravatinib fails in phase 3; down 11% | N/A | |
| 2023-05-20 15:59 EST | News | Mirati: The High Stakes Of Krazati's Market Performance Amidst Dwindling Cash (Rating Downgrade) | N/A | |
| 2023-05-10 05:10 EST | News | Mirati Therapeutics GAAP EPS of -$3.18 beats by $0.41, revenue of $7.17M beats by $2.37M | N/A | |
| 2023-05-10 05:10 EST | News | Mirati Therapeutics, Inc. 2023 Q1 - Results - Earnings Call Presentation | N/A | |
| 2023-05-10 05:10 EST | News | Mirati Therapeutics, Inc. (MRTX) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-05-09 15:56 EST | News | Sony, Mirati, Talen Energy pitched as long ideas at Sohn Investment conference (update) | N/A | |
| 2023-05-09 02:12 EST | News | Mirati Therapeutics Q1 2023 Earnings Preview | N/A | |
| 2023-03-20 16:26 EST | News | Mirati's Krazati: A Strong Competitor In The KRAS G12C-Mutated NSCLC Market | N/A | |
| 2023-02-28 22:55 EST | News | Mirati Therapeutics GAAP EPS of -$3.51 beats by $0.16, revenue of $0.93M misses by $1.72M | N/A | |
| 2023-02-28 22:54 EST | News | Mirati Therapeutics, Inc. (MRTX) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-02-28 07:14 EST | News | Mirati Therapeutics Q4 2022 Earnings Preview | N/A | |
| 2023-02-08 23:54 EST | News | Mirati Therapeutics: Suddenly A Battleground Stock | N/A | |
| 2023-01-19 20:59 EST | News | FDA clears Mirati's investigational new drug application for its inhibitor MRTX1133 | N/A | |
| 2022-12-22 01:06 EST | News | Mirati up 4% as Krazati granted Breakthough Therapy designation for colorectal cancer | N/A | |
| 2022-12-14 19:54 EST | News | Mirati draws Hold rating at Needham despite recent selloff | N/A | |
| 2022-12-13 09:09 EST | News | Mirati non-small cell lung cancer treatment adagrasib gains FDA approval - Bloomberg | N/A | |
| 2022-12-13 09:09 EST | News | Qiagen's test gets FDA nod for companion diagnostic to Mirati's cancer drug Krazati | N/A | |
| 2022-12-13 09:09 EST | News | Agilent's liquid biopsy test gets FDA nod for companion diagnostic test to Mirati's Krazati | N/A | |
| 2022-12-09 04:24 EST | News | Mirati Therapeutics down for third day as cancer data leads to analyst downgrades | N/A | |
| 2022-12-07 17:04 EST | News | Mirati slumps for second day on adagrasib lung cancer data; down 30% | N/A | |
| 2022-12-06 22:37 EST | News | Mirati stock dips amid trial data on adagrasib/Keytruda combo in lung cancer patients | N/A | |
| 2022-11-30 20:44 EST | News | Mirati Therapeutics: Is There A Big Pharma Buyout In Play And What's The Price Tag? | N/A | |
| 2022-11-29 09:30 EST | News | Mirati Therapeutics: Poised For Takeoff | N/A | |
| 2022-11-23 16:36 EST | News | Mirati Therapeutics gains again as JPMorgan sees possible $185-$200/share in takeout | N/A | |
| 2022-11-22 23:28 EST | News | Mirati Therapeutics jumps 13% on report of takeover interest | N/A | |
| 2022-11-22 23:28 EST | News | Mirati Therapeutics may be worth $200/share in takeover - analyst | N/A | |
| 2022-11-09 09:03 EST | News | Mirati Therapeutics GAAP EPS of -$3.09 beats by $0.40, revenue of $5.4M beats by $4.03M | N/A | |
| 2022-11-09 09:02 EST | News | Mirati Therapeutics, Inc. (MRTX) Q3 2022 - Earnings Call Transcript | N/A | |
| 2022-11-07 21:56 EST | News | Incyte, Mirati team up for trial of combo therapy for solid tumors | N/A | |
| 2022-11-07 21:55 EST | News | Mirati Therapeutics Q3 2022 Earnings Preview | N/A | |
| 2022-09-15 19:16 EST | News | Mirati wins bullish view at Piper on prospects for new cancer therapy | N/A | |
| 2022-09-15 19:15 EST | News | Amgen Vs. Mirati: Playing To Win In KRAS Mutated Lung Cancer | N/A | |
| 2022-09-09 07:46 EST | News | Mirati: A Potential Blockbuster Stock, Will Need Patience | N/A | |
| 2022-08-31 16:20 EST | News | Mirati jumps 11% as Amgen meets key goal for rival cancer drug | N/A | |
| 2022-08-15 02:10 EST | News | Amgen Lumakras combination data in lung cancer held until August - Reuters | N/A | |
| 2022-08-09 05:21 EST | News | Mirati gains as Amgen posts new combination data for rival cancer drug | N/A | |
| 2022-08-03 23:32 EST | News | Mirati Therapeutics GAAP EPS of -$3.18 beats by $0.32, revenue of $5.36M beats by $4.98M | N/A | |
| 2022-08-03 23:32 EST | News | Mirati Therapeutics, Inc. (MRTX) CEO David Meek on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-02 18:19 EST | News | Mirati Therapeutics Q2 2022 Earnings Preview | N/A | |
| 2022-06-24 10:25 EST | News | Mirati Therapeutics: Growth Cycle Transition | N/A | |
| 2022-06-22 05:16 EST | News | Mirati: Not Looking Good In 2022, But Stronger Prospects In 2-3 Years | N/A | |
| 2022-06-07 14:47 EST | News | Mirati rallies 25% most in over three years as JMP upgrades | N/A | |
| 2022-05-27 23:28 EST | News | Mirati extends losses after KRAS inhibitor data; Stifel says selloff is overdone | N/A | |
| 2022-05-27 06:52 EST | News | Mirati crashes after updating mid-stage data for KRAS inhibitor in lung cancer | N/A | |
| 2022-05-21 09:42 EST | News | Guggenheim analyst upgrades Mirati Therapeutics | N/A | |
| 2022-05-20 01:27 EST | News | Mirati submits European marketing application for mutated lung cancer treatment adagrasib | N/A | |
| 2022-05-17 12:54 EST | News | Mirati Therapeutics hires Laurie Stelzer as CFO | N/A | |
| 2022-05-13 21:50 EST | News | Mirati Therapeutics, Inc. 2022 Q1 - Results - Earnings Call Presentation | N/A | |
| 2022-05-05 06:22 EST | News | Mirati Therapeutics GAAP EPS of -$3.40 beats by $0.17, revenue of $0.71M beats by $0.53M | N/A | |
About Mirati Therapeutics, Inc (MRTX):
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase I/II clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; and Sitravatinib, an investigational spectrum-selective kinase inhibitor that is in Phase II clinical trial for the treatment of NSCL cancer, as well as a KRAS G12D inhibitor program, which is in preclinical development. It has a collaboration and license agreement with BeiGene, Ltd. to develop, manufacture, and commercialize sitravatinib; and a clinical collaboration agreement with Novartis Pharmaceuticals Corporation. Mirati Therapeutics, Inc. was founded in 1995 and is headquartered in San Diego, California.
General
- Name Mirati Therapeutics, Inc
- Symbol MRTX
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 199
- Last Split Factor1:50
- Last Split Date2013-07-03
- Fiscal Year EndDecember
- IPO Date2004-06-29
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.mirati.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 629.42
- Price/Book (Most Recent Quarter) 6.97
- Enterprise Value Revenue 607.79
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$8.72
- Next Year EPS Estimate -$7.64
- Next Quarter EPS Estimate -$2.15
- Operating Margin -2757%
- Return on Assets -24%
- Return on Equity -41%
- Revenue 13.4 million
- Earnings Per Share -$4.19
- Revenue Per Share $0.3
- Gross Profit 13.4 million
- Quarterly Earnings Growth 224.7%
View More
Highlights
- Market Capitalization 9.16 billion
- EBITDA -148816000
- Analyst Target Price $247.91
- Book Value Per Share $26.98
View More
Share Statistics
- Shares Outstanding 49.37 million
- Shares Float 35.43 million
- % Held by Insiders 180%
- % Held by Institutions 97.3%
- Shares Short 3.66 million
- Shares Short Prior Month 3.44 million
- Short Ratio 8.09
- Short % of Float 8%
- Short % of Shares Outstanding 7%
View More
Technicals
- Beta 1.48
- 52 Week High $249.42
- 52 Week Low $70.16
- 50 Day Moving Average 198.46
- 200 Day Moving Average 201.16
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Mirati Therapeutics, Inc (MRTX) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Mirati Therapeutics, Inc (MRTX) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-02-25 | $1.71 million | -$2.08 | -$2.19 | 4.94% |
| 2020-09-30 | 2020-11-04 | $N/A | -$1.96 | -$2.03 | 3.33% |
| 2020-06-30 | 2020-08-06 | $N/A | -$1.89 | -$2.10 | 9.8% |
| 2020-03-31 | 2020-05-07 | $N/A | -$2.02 | -$1.75 | -15.34% |
| 2019-12-31 | 2020-02-25 | $526000 | -$1.83 | -$1.42 | -28.74% |
| 2019-09-30 | 2019-11-04 | $988000 | -$1.38 | -$1.24 | -11.67% |
| 2019-06-30 | 2019-08-05 | $577000 | -$1.26 | -$1.20 | -5.38% |
| 2019-03-31 | 2019-04-29 | $1.24 million | -$1.17 | -$0.97 | -20.83% |
| 2018-12-31 | 2019-02-28 | $3.46 million | -$0.87 | -$0.84 | -3.04% |
| 2018-09-30 | 2018-11-06 | $N/A | -$0.85 | -$0.88 | 3.84% |
| 2018-06-30 | 2018-08-01 | $-9467000 | -$0.94 | -$0.82 | -14.86% |
| 2018-03-31 | 2018-05-07 | $9.47 million | -$0.51 | -$0.70 | 26.98% |
| 2017-12-31 | 2018-03-08 | $N/A | -$0.67 | -$0.64 | -4.65% |
| 2017-09-30 | 2017-11-01 | $N/A | -$0.65 | -$0.81 | 19.33% |
| 2017-06-30 | 2017-08-03 | $N/A | -$0.74 | -$0.80 | 7.74% |
| 2017-03-31 | 2017-05-04 | $N/A | -$0.73 | -$0.79 | 7.98% |
| 2016-12-31 | 2017-03-09 | $N/A | -$0.99 | -$1.01 | 2.11% |
| 2016-09-30 | 2016-11-03 | $N/A | -$0.97 | -$1.16 | 16.64% |
| 2016-06-30 | 2016-08-04 | $N/A | -$1.11 | -$1.15 | 3.1% |
| 2016-03-31 | 2016-05-05 | $N/A | -$1.13 | -$0.99 | -14.28% |
| 2015-12-31 | 2016-03-09 | $N/A | -$0.96 | -$1.03 | 7.06% |
| 2015-09-30 | 2015-11-06 | $N/A | -$1.11 | -$0.88 | -26.14% |
| 2015-06-30 | 2015-08-06 | $N/A | -$0.95 | -$0.74 | -28.38% |
| 2015-03-31 | 2015-05-06 | $N/A | -$0.77 | -$0.64 | -20.31% |
| 2014-12-31 | 2015-03-11 | $N/A | -$0.77 | -$0.83 | 7.23% |
| 2014-09-30 | 2014-11-10 | $N/A | -$0.64 | -$0.76 | 15.79% |
| 2014-06-30 | 2014-08-08 | $N/A | -$0.82 | -$0.69 | -18.84% |
| 2014-03-31 | 2014-05-15 | $N/A | -$0.99 | -$0.71 | -39.44% |
| 2013-12-31 | 2014-03-18 | $N/A | -$0.96 | -$0.74 | -30.39% |
| 2013-09-30 | 2013-11-12 | $N/A | -$3.06 | -$0.78 | -292.31% |
| 2013-06-30 | 2013-08-12 | $N/A | -$0.80 | ||
| 2013-03-31 | 2013-05-13 | $N/A | -$0.86 | ||
| 2012-12-31 | 2013-03-13 | $2015.72 | -$0.79 | ||
| 2012-09-30 | 2012-11-14 | $N/A | -$0.93 | ||
| 2012-06-30 | 2012-08-03 | $-1966.76 | -$0.74 |
Mirati Therapeutics, Inc (MRTX) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Mirati Therapeutics, Inc (MRTX) Chart:
Mirati Therapeutics, Inc (MRTX) News:
Below you will find a list of latest news for Mirati Therapeutics, Inc (MRTX) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Mirati Therapeutics, Inc (MRTX) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2024-06-21 | 30 | 0 | CALL | 0 | 0 | 96.48 | TRUE | 0 | 0 |
| 2024-06-21 | 35 | 0 | CALL | 0 | 0 | 34.66 | TRUE | 0 | 0 |
| 2024-06-21 | 40 | 18.8 | CALL | 0 | 8 | 60.72 | TRUE | 0 | 0 |
| 2024-06-21 | 45 | 0 | CALL | 0 | 0 | 15.78 | TRUE | 0 | 0 |
| 2024-06-21 | 47.5 | 0 | CALL | 0 | 0 | 39.33 | TRUE | 0 | 0 |
| 2024-06-21 | 50 | 8.9 | CALL | 0 | 9 | 32.81 | TRUE | 0 | 0 |
| 2024-06-21 | 52.5 | 6.3 | CALL | 0 | 50 | 26.47 | TRUE | 0 | 0 |
| 2024-06-21 | 55 | 3.7 | CALL | 0 | 13 | 20.2 | TRUE | 0 | 0 |
| 2024-06-21 | 57.5 | 1.3 | CALL | 0 | 2 | 0 | TRUE | 0 | 0 |
| 2024-06-21 | 60 | 0.05 | CALL | 0 | 137 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 62.5 | 2.2 | CALL | 10 | 20 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 65 | 0.2 | CALL | 0 | 3 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 70 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 75 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 80 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 30 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 35 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 40 | 0.1 | PUT | 0 | 78 | 32.57 | FALSE | 0 | 0 |
| 2024-06-21 | 45 | 0.05 | PUT | 0 | 5 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 47.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 50 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 52.5 | 1.41 | PUT | 0 | 10 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 55 | 0.05 | PUT | 0 | 29 | 7.78 | FALSE | 0 | 0 |
| 2024-06-21 | 57.5 | 0.05 | PUT | 0 | 6947 | 4.19 | FALSE | 0 | 0 |
| 2024-06-21 | 60 | 2 | PUT | 0 | 9 | 11.97 | TRUE | 0 | 0 |
| 2024-06-21 | 62.5 | 4.7 | PUT | 0 | 0 | 18.76 | TRUE | 0 | 0 |
| 2024-06-21 | 65 | 0 | PUT | 0 | 0 | 25.31 | TRUE | 0 | 0 |
| 2024-06-21 | 70 | 0 | PUT | 0 | 0 | 32.96 | TRUE | 0 | 0 |
| 2024-06-21 | 75 | 0 | PUT | 0 | 0 | 40.55 | TRUE | 0 | 0 |
| 2024-06-21 | 80 | 0 | PUT | 0 | 0 | 47.26 | TRUE | 0 | 0 |
| 2024-09-20 | 37.5 | 0 | CALL | 0 | 0 | 49.56 | TRUE | 0 | 0 |
| 2024-09-20 | 40 | 0 | CALL | 0 | 0 | 43.21 | TRUE | 0 | 0 |
| 2024-09-20 | 42.5 | 0 | CALL | 0 | 0 | 37.27 | TRUE | 0 | 0 |
| 2024-09-20 | 45 | 0 | CALL | 0 | 0 | 31.69 | TRUE | 0 | 0 |
| 2024-09-20 | 47.5 | 0 | CALL | 0 | 0 | 26.41 | TRUE | 0 | 0 |
| 2024-09-20 | 50 | 0 | CALL | 0 | 0 | 21.4 | TRUE | 0 | 0 |
| 2024-09-20 | 52.5 | 0 | CALL | 0 | 0 | 16.63 | TRUE | 0 | 0 |
| 2024-09-20 | 55 | 0 | CALL | 0 | 0 | 12.04 | TRUE | 0 | 0 |
| 2024-09-20 | 57.5 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-09-20 | 60 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 62.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 65 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 67.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 70 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 75 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 80 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 85 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 37.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 40 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 42.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 45 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 47.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 50 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 52.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 55 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 57.5 | 0.05 | PUT | 0 | 905 | 3.86 | FALSE | 0 | 0 |
| 2024-09-20 | 60 | 2.05 | PUT | 0 | 0 | 10.94 | TRUE | 0 | 0 |
| 2024-09-20 | 62.5 | 4.7 | PUT | 0 | 0 | 16.07 | TRUE | 0 | 0 |
| 2024-09-20 | 65 | 0 | PUT | 0 | 0 | 21.16 | TRUE | 0 | 0 |
| 2024-09-20 | 67.5 | 0 | PUT | 0 | 0 | 24 | TRUE | 0 | 0 |
| 2024-09-20 | 70 | 0 | PUT | 0 | 0 | 28.28 | TRUE | 0 | 0 |
| 2024-09-20 | 75 | 0 | PUT | 0 | 0 | 33.77 | TRUE | 0 | 0 |
| 2024-09-20 | 80 | 0 | PUT | 0 | 0 | 39.32 | TRUE | 0 | 0 |
| 2024-09-20 | 85 | 0 | PUT | 0 | 0 | 44.34 | TRUE | 0 | 0 |
| 2025-01-17 | 15 | 0 | CALL | 0 | 0 | 115.43 | TRUE | 0 | 0 |
| 2025-01-17 | 17.5 | 0 | CALL | 0 | 0 | 100.83 | TRUE | 0 | 0 |
| 2025-01-17 | 20 | 0 | CALL | 0 | 0 | 88.55 | TRUE | 0 | 0 |
| 2025-01-17 | 22.5 | 17.5 | CALL | 1 | 0 | 77.95 | TRUE | 0 | 0 |
| 2025-01-17 | 25 | 33.7 | CALL | 0 | 4 | 68.61 | TRUE | 0 | 0 |
| 2025-01-17 | 30 | 29.6 | CALL | 0 | 24 | 52.66 | TRUE | 0 | 0 |
| 2025-01-17 | 35 | 24.6 | CALL | 0 | 12 | 39.24 | TRUE | 0 | 0 |
| 2025-01-17 | 40 | 18.53 | CALL | 0 | 40 | 27.37 | TRUE | 0 | 0 |
| 2025-01-17 | 45 | 13.7 | CALL | 0 | 17 | 15.07 | TRUE | 0 | 0 |
| 2025-01-17 | 50 | 8.7 | CALL | 0 | 69 | 0 | TRUE | 0 | 0 |
| 2025-01-17 | 55 | 3.7 | CALL | 0 | 25 | 0 | TRUE | 0 | 0 |
| 2025-01-17 | 60 | 0.05 | CALL | 0 | 683 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 65 | 0.1 | CALL | 0 | 91 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 70 | 0.05 | CALL | 0 | 97 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 75 | 0.5 | CALL | 0 | 16 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 80 | 0.5 | CALL | 2 | 7 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 85 | 0.2 | CALL | 0 | 4 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 90 | 6 | CALL | 2 | 2 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 95 | 4 | CALL | 0 | 13 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 100 | 0.05 | CALL | 5 | 389 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 105 | 0.05 | CALL | 1 | 24 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 110 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 115 | 0.05 | CALL | 3 | 4 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 120 | 0.05 | CALL | 2 | 2 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 125 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 130 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 135 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 140 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 145 | 1.6 | CALL | 1 | 4 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 15 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 17.5 | 2.2 | PUT | 1 | 0 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 20 | 0.5 | PUT | 1 | 13 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 22.5 | 1.25 | PUT | 100 | 102 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 25 | 0.1 | PUT | 2 | 6 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 30 | 0.05 | PUT | 0 | 55 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 35 | 0.05 | PUT | 0 | 41 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 40 | 0.1 | PUT | 0 | 106 | 22.23 | FALSE | 0 | 0 |
| 2025-01-17 | 45 | 0.05 | PUT | 0 | 1264 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 50 | 0.05 | PUT | 0 | 803 | 10.55 | FALSE | 0 | 0 |
| 2025-01-17 | 55 | 0.05 | PUT | 0 | 548 | 6.16 | FALSE | 0 | 0 |
| 2025-01-17 | 60 | 2 | PUT | 0 | 5 | 9.87 | TRUE | 0 | 0 |
| 2025-01-17 | 65 | 7.1 | PUT | 0 | 5 | 19.12 | TRUE | 0 | 0 |
| 2025-01-17 | 70 | 41.5 | PUT | 1 | 2 | 28.01 | TRUE | 0 | 0 |
| 2025-01-17 | 75 | 45 | PUT | 2 | 4 | 30.6 | TRUE | 0 | 0 |
| 2025-01-17 | 80 | 51.1 | PUT | 1 | 1 | 35.48 | TRUE | 0 | 0 |
| 2025-01-17 | 85 | 43.2 | PUT | 1 | 1 | 39.87 | TRUE | 0 | 0 |
| 2025-01-17 | 90 | 0 | PUT | 0 | 0 | 43.9 | TRUE | 0 | 0 |
| 2025-01-17 | 95 | 0 | PUT | 0 | 0 | 47.63 | TRUE | 0 | 0 |
| 2025-01-17 | 100 | 0 | PUT | 0 | 0 | 51.1 | TRUE | 0 | 0 |
| 2025-01-17 | 105 | 0 | PUT | 0 | 0 | 54.35 | TRUE | 0 | 0 |
| 2025-01-17 | 110 | 0 | PUT | 0 | 0 | 57.42 | TRUE | 0 | 0 |
| 2025-01-17 | 115 | 0 | PUT | 0 | 0 | 60.33 | TRUE | 0 | 0 |
| 2025-01-17 | 120 | 0 | PUT | 0 | 0 | 63.1 | TRUE | 0 | 0 |
| 2025-01-17 | 125 | 0 | PUT | 0 | 0 | 65.74 | TRUE | 0 | 0 |
| 2025-01-17 | 130 | 0 | PUT | 0 | 0 | 68.27 | TRUE | 0 | 0 |
| 2025-01-17 | 135 | 0 | PUT | 0 | 0 | 70.69 | TRUE | 0 | 0 |
| 2025-01-17 | 140 | 0 | PUT | 0 | 0 | 73.01 | TRUE | 0 | 0 |
| 2025-01-17 | 145 | 0 | PUT | 0 | 0 | 75.25 | TRUE | 0 | 0 |
Latest MRTX Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 3 | $53.795 |
| Jun 13, 2022 7:59 PM EST | 400 | $53.78 |
| Jun 13, 2022 7:59 PM EST | 100 | $53.78 |
| Jun 13, 2022 7:59 PM EST | 100 | $53.77 |
| Jun 13, 2022 7:59 PM EST | 70 | $53.82 |
Mirati Therapeutics, Inc (MRTX) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-07-02 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1576263/000119312520186895/0001193125-20-186895-index.htm |
| 2019-02-08 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1576263/000021545719006709/0000215457-19-006709-index.htm |
| 2019-02-13 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1576263/000031506619001176/0000315066-19-001176-index.htm |
| 2019-03-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1576263/000031506619001462/0000315066-19-001462-index.htm |
| 2019-08-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1576263/000031506619001679/0000315066-19-001679-index.htm |
| 2020-02-07 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1576263/000031506620001063/0000315066-20-001063-index.htm |
| 2020-02-05 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1576263/000083423720005810/0000834237-20-005810-index.htm |
| 2019-01-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000089924319001646/0000899243-19-001646-index.htm |
| 2019-02-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000089924319003425/0000899243-19-003425-index.htm |
| 2019-02-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000089924319004564/0000899243-19-004564-index.htm |
| 2019-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000089924319006351/0000899243-19-006351-index.htm |
| 2019-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000089924319006352/0000899243-19-006352-index.htm |
| 2019-04-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000089924319010289/0000899243-19-010289-index.htm |
| 2019-04-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000089924319010290/0000899243-19-010290-index.htm |
| 2019-04-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000089924319010291/0000899243-19-010291-index.htm |
| 2019-05-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000089924319014657/0000899243-19-014657-index.htm |
| 2019-07-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000089924319019615/0000899243-19-019615-index.htm |
| 2019-07-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000089924319019989/0000899243-19-019989-index.htm |
| 2020-01-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000089924320001161/0000899243-20-001161-index.htm |
| 2020-06-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000089924320016664/0000899243-20-016664-index.htm |
| 2020-06-16 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000089924320016700/0000899243-20-016700-index.htm |
| 2020-10-30 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000089924320030049/0000899243-20-030049-index.htm |
| 2020-10-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000089924320030059/0000899243-20-030059-index.htm |
| 2020-10-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000089924320030060/0000899243-20-030060-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1576263/000090266419001007/0000902664-19-001007-index.htm |
| 2019-02-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000090266419001248/0000902664-19-001248-index.htm |
| 2019-03-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000090266419001604/0000902664-19-001604-index.htm |
| 2019-07-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000090266419003156/0000902664-19-003156-index.htm |
| 2019-07-25 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1576263/000090266419003157/0000902664-19-003157-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1576263/000090266420001112/0000902664-20-001112-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1576263/000091957419001188/0000919574-19-001188-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1576263/000092963819000274/0000929638-19-000274-index.htm |
| 2019-11-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1576263/000092963819001000/0000929638-19-001000-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1576263/000092963820000325/0000929638-20-000325-index.htm |
| 2020-02-11 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1576263/000110465920016324/0001104659-20-016324-index.htm |
| 2019-07-30 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1576263/000114420419036698/0001144204-19-036698-index.htm |
| 2019-10-04 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1576263/000114420419047371/0001144204-19-047371-index.htm |
| 2019-07-01 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000119072519000021/0001190725-19-000021-index.htm |
| 2019-07-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000119072519000022/0001190725-19-000022-index.htm |
| 2019-01-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1576263/000119312519011509/0001193125-19-011509-index.htm |
| 2019-04-29 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1576263/000119312519125108/0001193125-19-125108-index.htm |
| 2019-05-02 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1576263/000119312519133897/0001193125-19-133897-index.htm |
| 2019-05-16 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1576263/000119312519148629/0001193125-19-148629-index.htm |
| 2019-05-24 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1576263/000119312519155765/0001193125-19-155765-index.htm |
| 2019-06-24 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1576263/000119312519180049/0001193125-19-180049-index.htm |
| 2019-06-25 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1576263/000119312519181179/0001193125-19-181179-index.htm |
| 2019-06-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1576263/000119312519181189/0001193125-19-181189-index.htm |
| 2019-07-19 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1576263/000119312519198165/0001193125-19-198165-index.htm |
| 2019-08-05 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1576263/000119312519213049/0001193125-19-213049-index.htm |
| 2019-10-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1576263/000119312519276327/0001193125-19-276327-index.htm |
| 2019-11-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1576263/000119312519289086/0001193125-19-289086-index.htm |
| 2019-12-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1576263/000119312519326601/0001193125-19-326601-index.htm |
| 2019-12-31 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1576263/000119312519326654/0001193125-19-326654-index.htm |
| 2020-01-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1576263/000119312520002221/0001193125-20-002221-index.htm |
| 2020-01-08 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1576263/000119312520003886/0001193125-20-003886-index.htm |
| 2020-01-10 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1576263/000119312520005389/0001193125-20-005389-index.htm |
| 2020-01-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1576263/000119312520005396/0001193125-20-005396-index.htm |
| 2020-01-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1576263/000119312520005839/0001193125-20-005839-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1576263/000119312520038229/0001193125-20-038229-index.htm |
| 2020-02-14 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1576263/000119312520038469/0001193125-20-038469-index.htm |
| 2020-07-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1576263/000119312520186838/0001193125-20-186838-index.htm |
| 2020-07-02 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1576263/000119312520186895/0001193125-20-186895-index.htm |
| 2020-10-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1576263/000119312520276089/0001193125-20-276089-index.htm |
| 2020-10-26 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1576263/000119312520277042/0001193125-20-277042-index.htm |
| 2020-10-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1576263/000119312520277044/0001193125-20-277044-index.htm |
| 2020-10-28 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1576263/000119312520279890/0001193125-20-279890-index.htm |
| 2020-10-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1576263/000119312520279899/0001193125-20-279899-index.htm |
| 2020-11-02 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1576263/000119312520282990/0001193125-20-282990-index.htm |
| 2019-01-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465919000451/0001214659-19-000451-index.htm |
| 2019-01-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465919000452/0001214659-19-000452-index.htm |
| 2019-01-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465919000453/0001214659-19-000453-index.htm |
| 2019-01-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465919000454/0001214659-19-000454-index.htm |
| 2019-01-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465919000455/0001214659-19-000455-index.htm |
| 2019-01-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465919000456/0001214659-19-000456-index.htm |
| 2019-01-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465919000457/0001214659-19-000457-index.htm |
| 2019-01-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465919000458/0001214659-19-000458-index.htm |
| 2019-01-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465919000459/0001214659-19-000459-index.htm |
| 2019-01-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465919000460/0001214659-19-000460-index.htm |
| 2019-01-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465919000461/0001214659-19-000461-index.htm |
| 2019-01-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465919000462/0001214659-19-000462-index.htm |
| 2019-01-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465919000538/0001214659-19-000538-index.htm |
| 2019-01-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465919000676/0001214659-19-000676-index.htm |
| 2019-02-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465919001353/0001214659-19-001353-index.htm |
| 2019-02-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465919001354/0001214659-19-001354-index.htm |
| 2019-02-20 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465919001388/0001214659-19-001388-index.htm |
| 2019-02-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465919001392/0001214659-19-001392-index.htm |
| 2019-02-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465919001445/0001214659-19-001445-index.htm |
| 2019-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465919001486/0001214659-19-001486-index.htm |
| 2019-02-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465919001618/0001214659-19-001618-index.htm |
| 2019-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465919003616/0001214659-19-003616-index.htm |
| 2019-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465919003693/0001214659-19-003693-index.htm |
| 2019-05-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465919003824/0001214659-19-003824-index.htm |
| 2019-08-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465919005304/0001214659-19-005304-index.htm |
| 2019-08-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465919005435/0001214659-19-005435-index.htm |
| 2019-08-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465919005436/0001214659-19-005436-index.htm |
| 2019-11-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465919007223/0001214659-19-007223-index.htm |
| 2019-11-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465919007373/0001214659-19-007373-index.htm |
| 2019-12-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465919007835/0001214659-19-007835-index.htm |
| 2019-12-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465919008005/0001214659-19-008005-index.htm |
| 2019-12-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465919008006/0001214659-19-008006-index.htm |
| 2020-01-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465920000191/0001214659-20-000191-index.htm |
| 2020-01-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465920000192/0001214659-20-000192-index.htm |
| 2020-01-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465920000193/0001214659-20-000193-index.htm |
| 2020-01-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465920000194/0001214659-20-000194-index.htm |
| 2020-01-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465920000195/0001214659-20-000195-index.htm |
| 2020-01-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465920000196/0001214659-20-000196-index.htm |
| 2020-01-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465920000197/0001214659-20-000197-index.htm |
| 2020-01-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465920000198/0001214659-20-000198-index.htm |
| 2020-01-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465920000199/0001214659-20-000199-index.htm |
| 2020-01-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465920000200/0001214659-20-000200-index.htm |
| 2020-01-08 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465920000224/0001214659-20-000224-index.htm |
| 2020-01-08 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465920000225/0001214659-20-000225-index.htm |
| 2020-01-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465920000226/0001214659-20-000226-index.htm |
| 2020-01-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465920000227/0001214659-20-000227-index.htm |
| 2020-01-15 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465920000359/0001214659-20-000359-index.htm |
| 2020-01-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465920000360/0001214659-20-000360-index.htm |
| 2020-01-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465920000769/0001214659-20-000769-index.htm |
| 2020-02-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465920001004/0001214659-20-001004-index.htm |
| 2020-03-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465920002048/0001214659-20-002048-index.htm |
| 2020-03-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465920002971/0001214659-20-002971-index.htm |
| 2020-03-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465920003016/0001214659-20-003016-index.htm |
| 2020-04-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465920003519/0001214659-20-003519-index.htm |
| 2020-04-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465920003604/0001214659-20-003604-index.htm |
| 2020-04-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465920003834/0001214659-20-003834-index.htm |
| 2020-05-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465920004484/0001214659-20-004484-index.htm |
| 2020-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465920004864/0001214659-20-004864-index.htm |
| 2020-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465920004964/0001214659-20-004964-index.htm |
| 2020-07-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465920006523/0001214659-20-006523-index.htm |
| 2020-08-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465920006974/0001214659-20-006974-index.htm |
| 2020-08-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465920007045/0001214659-20-007045-index.htm |
| 2020-11-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465920009173/0001214659-20-009173-index.htm |
| 2020-11-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1576263/000121465920009226/0001214659-20-009226-index.htm |
| 2019-01-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1576263/000162828019000469/0001628280-19-000469-index.htm |
| 2019-02-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1576263/000162828019001605/0001628280-19-001605-index.htm |
| 2019-02-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1576263/000162828019002282/0001628280-19-002282-index.htm |
| 2019-02-28 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1576263/000162828019002289/0001628280-19-002289-index.htm |
| 2019-04-19 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1576263/000162828019004534/0001628280-19-004534-index.htm |
| 2019-04-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1576263/000162828019004720/0001628280-19-004720-index.htm |
| 2019-04-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1576263/000162828019004929/0001628280-19-004929-index.htm |
| 2019-04-29 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1576263/000162828019004931/0001628280-19-004931-index.htm |
| 2019-05-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1576263/000162828019006833/0001628280-19-006833-index.htm |
| 2019-07-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1576263/000162828019008484/0001628280-19-008484-index.htm |
| 2019-08-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1576263/000162828019009964/0001628280-19-009964-index.htm |
| 2019-08-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1576263/000162828019009968/0001628280-19-009968-index.htm |
| 2019-08-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1576263/000162828019011248/0001628280-19-011248-index.htm |
| 2019-11-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1576263/000162828019013206/0001628280-19-013206-index.htm |
| 2019-11-04 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1576263/000162828019013209/0001628280-19-013209-index.htm |
| 2020-02-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1576263/000162828020002153/0001628280-20-002153-index.htm |
| 2020-02-26 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1576263/000162828020002301/0001628280-20-002301-index.htm |
| 2020-04-17 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1576263/000162828020005116/0001628280-20-005116-index.htm |
| 2020-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1576263/000162828020006956/0001628280-20-006956-index.htm |
| 2020-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1576263/000162828020006965/0001628280-20-006965-index.htm |
| 2020-05-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1576263/000162828020007562/0001628280-20-007562-index.htm |
| 2020-05-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1576263/000162828020007978/0001628280-20-007978-index.htm |
| 2020-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1576263/000162828020011996/0001628280-20-011996-index.htm |
| 2020-08-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1576263/000162828020012012/0001628280-20-012012-index.htm |
| 2020-11-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1576263/000162828020015516/0001628280-20-015516-index.htm |
| 2020-11-04 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1576263/000162828020015518/0001628280-20-015518-index.htm |
| 2019-04-26 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1576263/999999999719003507/9999999997-19-003507-index.htm |
Mirati Therapeutics, Inc (MRTX) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Mirati Therapeutics, Inc (MRTX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 180%Institutional Ownership: 9730%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2019-02-20 | BRUCE L A CARTER | Director | Sell | 1,100.00 | 74.44 | 81,882.02 | 0.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919001445/0001214659-19-001445-index.htm |
| 2019-05-22 | BRUCE L A CARTER | Director | Sell | 3,000.00 | 75.20 | 225,596.70 | 0.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919003824/0001214659-19-003824-index.htm |
| 2019-08-21 | BRUCE L A CARTER | Director | Sell | 3,000.00 | 89.24 | 267,720.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919005435/0001214659-19-005435-index.htm |
| 2019-11-20 | BRUCE L A CARTER | Director | Sell | 3,000.00 | 94.74 | 284,220.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919007373/0001214659-19-007373-index.htm |
| 2019-02-14 | CHRISTOPHER C. LEMASTERS | EVP, Chief Business Officer | Sell | 18,562.00 | 72.06 | 1,337,488.62 | 0.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919001353/0001214659-19-001353-index.htm |
| 2019-01-29 | Craig A Johnson | Director | Sell | 8,525.00 | 61.80 | 526,831.36 | 0.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919000676/0001214659-19-000676-index.htm |
| 2020-02-04 | CHARLES M BAUM | President & CEO | Buy | 2,396.00 | 24.99 | 59,876.04 | 101,884.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465920001004/0001214659-20-001004-index.htm |
| 2020-02-28 | CHARLES M BAUM | President & CEO | Buy | 2,291.00 | 5.40 | 12,371.40 | 104,175.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465920002048/0001214659-20-002048-index.htm |
| 2020-08-10 | HENRY J FUCHS | Director | Sell | 900.00 | 128.56 | 115,706.97 | 10,600.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465920006974/0001214659-20-006974-index.htm |
| 2019-08-22 | CHARLES M BAUM | President & CEO | Sell | 11,843.00 | 85.03 | 1,006,996.08 | 106,008.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919005436/0001214659-19-005436-index.htm |
| 2020-03-27 | CHARLES M BAUM | President & CEO | Buy | 2,291.00 | 5.40 | 12,371.40 | 106,466.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465920003016/0001214659-20-003016-index.htm |
| 2020-04-17 | CHARLES M BAUM | President & CEO | Sell | 4,290.00 | 91.63 | 393,092.27 | 106,466.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465920003519/0001214659-20-003519-index.htm |
| 2020-04-27 | CHARLES M BAUM | President & CEO | Buy | 557.00 | 5.40 | 3,007.80 | 107,023.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465920003834/0001214659-20-003834-index.htm |
| 2019-02-20 | BRUCE L A CARTER | Director | Sell | 1,000.00 | 73.79 | 73,789.00 | 1,100.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919001445/0001214659-19-001445-index.htm |
| 2020-04-17 | CHARLES M BAUM | President & CEO | Sell | 25,184.00 | 90.41 | 2,276,958.47 | 110,756.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465920003519/0001214659-20-003519-index.htm |
| 2020-08-10 | HENRY J FUCHS | Director | Sell | 500.00 | 127.52 | 63,762.00 | 11,500.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465920006974/0001214659-20-006974-index.htm |
| 2019-12-23 | Jamie Christensen | EVP, Chief Scientific Officer | Buy | 2,499.00 | 5.50 | 13,744.50 | 11,658.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919008005/0001214659-19-008005-index.htm |
| 2019-02-25 | CHARLES M BAUM | President & CEO | Buy | 51,810.00 | 8.50 | 440,385.00 | 117,851.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919001618/0001214659-19-001618-index.htm |
| 2019-08-22 | CHARLES M BAUM | President & CEO | Buy | 51,810.00 | 8.50 | 440,385.00 | 117,851.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919005436/0001214659-19-005436-index.htm |
| 2020-08-10 | HENRY J FUCHS | Director | Buy | 10,000.00 | 20.54 | 205,400.00 | 12,000.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465920006974/0001214659-20-006974-index.htm |
| 2019-03-01 | Boxer Capital, LLC | 10% Share Holder | Sell | 425,000.00 | 69.00 | 29,325,000.00 | 1,290,560.00 | https://www.sec.gov/Archives/edgar/data/1576263/000089924319006352/0000899243-19-006352-index.htm |
| 2019-12-23 | Jamie Christensen | EVP, Chief Scientific Officer | Buy | 4,167.00 | 5.40 | 22,501.80 | 13,326.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919008005/0001214659-19-008005-index.htm |
| 2019-05-13 | MICHAEL G GREY | Director | Sell | 300.00 | 66.08 | 19,824.51 | 1,340.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919003616/0001214659-19-003616-index.htm |
| 2020-04-17 | CHARLES M BAUM | President & CEO | Sell | 10,526.00 | 89.59 | 943,058.02 | 135,940.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465920003519/0001214659-20-003519-index.htm |
| 2020-10-30 | Boxer Capital, LLC | 10% Share Holder | Sell | 362,950.00 | 202.00 | 73,315,900.00 | 1,404,610.00 | https://www.sec.gov/Archives/edgar/data/1576263/000089924320030060/0000899243-20-030060-index.htm |
| 2020-04-17 | CHARLES M BAUM | President & CEO | Buy | 40,000.00 | 8.49 | 339,600.00 | 146,466.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465920003519/0001214659-20-003519-index.htm |
| 2019-05-13 | MICHAEL G GREY | Director | Sell | 5,460.00 | 65.26 | 356,313.59 | 1,640.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919003616/0001214659-19-003616-index.htm |
| 2019-01-29 | Craig A Johnson | Director | Buy | 10,000.00 | 3.65 | 36,500.00 | 17,000.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919000676/0001214659-19-000676-index.htm |
| 2020-04-20 | Craig A Johnson | Director | Buy | 15,000.00 | 25.84 | 387,600.00 | 17,000.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465920003604/0001214659-20-003604-index.htm |
| 2019-01-17 | Boxer Capital, LLC | 10% Share Holder | Buy | 150,000.00 | 62.00 | 9,300,000.00 | 1,715,560.00 | https://www.sec.gov/Archives/edgar/data/1576263/000089924319001646/0000899243-19-001646-index.htm |
| 2019-07-17 | Boxer Capital, LLC | 10% Share Holder | Sell | 8.00 | 103.45 | 827.60 | 1,715,560.00 | https://www.sec.gov/Archives/edgar/data/1576263/000089924319019989/0000899243-19-019989-index.htm |
| 2019-03-01 | Boxer Capital, LLC | 10% Share Holder | Buy | 425,006.00 | 0.00 | 425.01 | 1,715,566.00 | https://www.sec.gov/Archives/edgar/data/1576263/000089924319006352/0000899243-19-006352-index.htm |
| 2020-01-10 | Boxer Capital, LLC | 10% Share Holder | Buy | 50,000.00 | 97.50 | 4,875,000.00 | 1,765,560.00 | https://www.sec.gov/Archives/edgar/data/1576263/000089924320001161/0000899243-20-001161-index.htm |
| 2020-10-30 | Boxer Capital, LLC | 10% Share Holder | Buy | 362,952.00 | 0.00 | 362.95 | 1,765,562.00 | https://www.sec.gov/Archives/edgar/data/1576263/000089924320030060/0000899243-20-030060-index.htm |
| 2019-08-12 | MICHAEL G GREY | Director | Sell | 260.00 | 93.98 | 24,433.60 | 1,798.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919005304/0001214659-19-005304-index.htm |
| 2019-02-14 | CHRISTOPHER C. LEMASTERS | EVP, Chief Business Officer | Sell | 41,438.00 | 71.65 | 2,968,966.40 | 18,562.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919001353/0001214659-19-001353-index.htm |
| 2020-01-03 | BRUCE L A CARTER | Director | Buy | 2,000.00 | 2,000.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465920000196/0001214659-20-000196-index.htm | ||
| 2020-05-18 | BRUCE L A CARTER | Director | Sell | 4,000.00 | 106.86 | 427,440.40 | 2,000.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465920004864/0001214659-20-004864-index.htm |
| 2020-08-11 | BRUCE L A CARTER | Director | Sell | 100.00 | 131.16 | 13,116.00 | 2,000.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465920007045/0001214659-20-007045-index.htm |
| 2020-01-03 | Craig A Johnson | Director | Buy | 2,000.00 | 2,000.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465920000191/0001214659-20-000191-index.htm | ||
| 2020-04-20 | Craig A Johnson | Director | Sell | 15,000.00 | 93.00 | 1,395,000.00 | 2,000.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465920003604/0001214659-20-003604-index.htm |
| 2020-01-03 | HENRY J FUCHS | Director | Buy | 2,000.00 | 2,000.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465920000193/0001214659-20-000193-index.htm | ||
| 2020-08-10 | HENRY J FUCHS | Director | Sell | 500.00 | 133.07 | 66,536.00 | 2,000.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465920006974/0001214659-20-006974-index.htm |
| 2020-01-03 | Julie M Cherrington | Director | Buy | 2,000.00 | 2,000.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465920000198/0001214659-20-000198-index.htm | ||
| 2020-01-03 | Maria E Martinez | Director | Buy | 2,000.00 | 2,000.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465920000197/0001214659-20-000197-index.htm | ||
| 2019-08-12 | MICHAEL G GREY | Director | Sell | 650.00 | 93.18 | 60,569.47 | 2,058.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919005304/0001214659-19-005304-index.htm |
| 2019-02-20 | BRUCE L A CARTER | Director | Sell | 900.00 | 72.50 | 65,250.00 | 2,100.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919001445/0001214659-19-001445-index.htm |
| 2020-08-11 | BRUCE L A CARTER | Director | Sell | 110.00 | 127.58 | 14,033.90 | 2,100.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465920007045/0001214659-20-007045-index.htm |
| 2020-10-30 | Boxer Capital, LLC | 10% Share Holder | Sell | 37,050.00 | 202.00 | 7,484,100.00 | 216,288.00 | https://www.sec.gov/Archives/edgar/data/1576263/000089924320030060/0000899243-20-030060-index.htm |
| 2020-01-06 | Benjamin Hickey | EVP, Chief Commercial Officer | Buy | 21,867.00 | 21,867.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465920000226/0001214659-20-000226-index.htm | ||
| 2019-02-15 | Jamie A Donadio | Sr. VP, CFO | Sell | 7,500.00 | 75.00 | 562,501.50 | 221.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919001354/0001214659-19-001354-index.htm |
| 2019-05-16 | Jamie A Donadio | Sr. VP, CFO | Sell | 7,500.00 | 75.00 | 562,500.00 | 221.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919003693/0001214659-19-003693-index.htm |
| 2020-08-11 | BRUCE L A CARTER | Director | Sell | 740.00 | 126.71 | 93,766.81 | 2,210.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465920007045/0001214659-20-007045-index.htm |
| 2019-11-12 | MICHAEL G GREY | Director | Sell | 3,042.00 | 102.44 | 311,622.48 | 2,256.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919007223/0001214659-19-007223-index.htm |
| 2020-01-03 | Jamie Christensen | EVP, Chief Scientific Officer | Buy | 15,625.00 | 24,784.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465920000200/0001214659-20-000200-index.htm | ||
| 2020-08-10 | HENRY J FUCHS | Director | Sell | 5,800.00 | 132.34 | 767,567.94 | 2,500.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465920006974/0001214659-20-006974-index.htm |
| 2020-10-30 | Boxer Capital, LLC | 10% Share Holder | Buy | 37,051.00 | 0.00 | 37.05 | 253,339.00 | https://www.sec.gov/Archives/edgar/data/1576263/000089924320030060/0000899243-20-030060-index.htm |
| 2020-06-12 | Ltd. Braslyn | 10% Share Holder | Sell | 600,000.00 | 69.00 | 41,400,000.00 | 2,535,966.00 | https://www.sec.gov/Archives/edgar/data/1576263/000089924320016664/0000899243-20-016664-index.htm |
| 2020-01-06 | Daniel Faga | EVP, Chief Operating Officer | Buy | 26,240.00 | 26,240.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465920000227/0001214659-20-000227-index.htm | ||
| 2019-08-12 | MICHAEL G GREY | Director | Sell | 1,100.00 | 92.34 | 101,574.77 | 2,708.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919005304/0001214659-19-005304-index.htm |
| 2020-03-26 | Jamie Christensen | EVP, Chief Scientific Officer | Buy | 2,580.00 | 24.99 | 64,474.20 | 27,364.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465920002971/0001214659-20-002971-index.htm |
| 2020-10-28 | Ltd. Braslyn | 10% Share Holder | Sell | 500.00 | 211.06 | 105,531.50 | 2,840,530.00 | https://www.sec.gov/Archives/edgar/data/1576263/000089924320030059/0000899243-20-030059-index.htm |
| 2020-10-28 | Ltd. Braslyn | 10% Share Holder | Sell | 23,283.00 | 210.31 | 4,896,647.73 | 2,841,030.00 | https://www.sec.gov/Archives/edgar/data/1576263/000089924320030059/0000899243-20-030059-index.htm |
| 2019-03-01 | Ltd. Braslyn | 10% Share Holder | Sell | 275,000.00 | 69.00 | 18,975,000.00 | 2,860,966.00 | https://www.sec.gov/Archives/edgar/data/1576263/000089924319006351/0000899243-19-006351-index.htm |
| 2020-03-26 | Jamie Christensen | EVP, Chief Scientific Officer | Buy | 1,256.00 | 5.50 | 6,908.00 | 28,620.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465920002971/0001214659-20-002971-index.htm |
| 2020-10-28 | Ltd. Braslyn | 10% Share Holder | Sell | 37,428.00 | 209.47 | 7,840,043.16 | 2,864,313.00 | https://www.sec.gov/Archives/edgar/data/1576263/000089924320030059/0000899243-20-030059-index.htm |
| 2020-10-28 | Ltd. Braslyn | 10% Share Holder | Sell | 25,036.00 | 208.40 | 5,217,502.40 | 2,901,741.00 | https://www.sec.gov/Archives/edgar/data/1576263/000089924320030059/0000899243-20-030059-index.htm |
| 2020-10-28 | Ltd. Braslyn | 10% Share Holder | Sell | 38,525.00 | 207.35 | 7,988,158.75 | 2,926,777.00 | https://www.sec.gov/Archives/edgar/data/1576263/000089924320030059/0000899243-20-030059-index.htm |
| 2020-08-11 | BRUCE L A CARTER | Director | Sell | 1,300.00 | 125.78 | 163,511.79 | 2,950.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465920007045/0001214659-20-007045-index.htm |
| 2020-10-28 | Ltd. Braslyn | 10% Share Holder | Sell | 41,266.00 | 206.50 | 8,521,429.00 | 2,965,302.00 | https://www.sec.gov/Archives/edgar/data/1576263/000089924320030059/0000899243-20-030059-index.htm |
| 2019-02-20 | BRUCE L A CARTER | Director | Buy | 3,000.00 | 6.78 | 20,340.00 | 3,000.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919001445/0001214659-19-001445-index.htm |
| 2019-05-22 | BRUCE L A CARTER | Director | Buy | 3,000.00 | 6.78 | 20,340.00 | 3,000.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919003824/0001214659-19-003824-index.htm |
| 2019-08-21 | BRUCE L A CARTER | Director | Buy | 3,000.00 | 6.78 | 20,340.00 | 3,000.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919005435/0001214659-19-005435-index.htm |
| 2019-11-20 | BRUCE L A CARTER | Director | Buy | 3,000.00 | 6.78 | 20,340.00 | 3,000.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919007373/0001214659-19-007373-index.htm |
| 2020-01-03 | Faheem Hasnain | Director | Buy | 3,000.00 | 3,000.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465920000195/0001214659-20-000195-index.htm | ||
| 2020-10-28 | Ltd. Braslyn | 10% Share Holder | Sell | 45,896.00 | 205.49 | 9,431,169.04 | 3,006,568.00 | https://www.sec.gov/Archives/edgar/data/1576263/000089924320030059/0000899243-20-030059-index.htm |
| 2020-10-29 | Ltd. Braslyn | 10% Share Holder | Sell | 818.00 | 220.02 | 179,979.63 | 3,031,402.00 | https://www.sec.gov/Archives/edgar/data/1576263/000089924320030059/0000899243-20-030059-index.htm |
| 2020-10-29 | Ltd. Braslyn | 10% Share Holder | Sell | 663.00 | 218.85 | 145,097.55 | 3,032,220.00 | https://www.sec.gov/Archives/edgar/data/1576263/000089924320030059/0000899243-20-030059-index.htm |
| 2020-10-29 | Ltd. Braslyn | 10% Share Holder | Sell | 5,912.00 | 218.04 | 1,289,025.28 | 3,032,883.00 | https://www.sec.gov/Archives/edgar/data/1576263/000089924320030059/0000899243-20-030059-index.htm |
| 2020-10-29 | Ltd. Braslyn | 10% Share Holder | Sell | 6,775.00 | 217.14 | 1,471,156.70 | 3,038,795.00 | https://www.sec.gov/Archives/edgar/data/1576263/000089924320030059/0000899243-20-030059-index.htm |
| 2020-10-29 | Ltd. Braslyn | 10% Share Holder | Sell | 11,656.00 | 216.06 | 2,518,338.25 | 3,045,570.00 | https://www.sec.gov/Archives/edgar/data/1576263/000089924320030059/0000899243-20-030059-index.htm |
| 2020-10-28 | Ltd. Braslyn | 10% Share Holder | Sell | 38,543.00 | 204.57 | 7,884,741.51 | 3,052,464.00 | https://www.sec.gov/Archives/edgar/data/1576263/000089924320030059/0000899243-20-030059-index.htm |
| 2020-10-29 | Ltd. Braslyn | 10% Share Holder | Sell | 27,992.00 | 215.08 | 6,020,396.20 | 3,057,226.00 | https://www.sec.gov/Archives/edgar/data/1576263/000089924320030059/0000899243-20-030059-index.htm |
| 2020-03-26 | Jamie Christensen | EVP, Chief Scientific Officer | Buy | 2,084.00 | 5.40 | 11,253.60 | 30,704.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465920002971/0001214659-20-002971-index.htm |
| 2020-10-29 | Ltd. Braslyn | 10% Share Holder | Sell | 2,344.00 | 214.31 | 502,335.37 | 3,085,218.00 | https://www.sec.gov/Archives/edgar/data/1576263/000089924320030059/0000899243-20-030059-index.htm |
| 2020-10-29 | Ltd. Braslyn | 10% Share Holder | Sell | 3,108.00 | 212.66 | 660,946.66 | 3,087,562.00 | https://www.sec.gov/Archives/edgar/data/1576263/000089924320030059/0000899243-20-030059-index.htm |
| 2020-10-29 | Ltd. Braslyn | 10% Share Holder | Sell | 14,408.00 | 211.50 | 3,047,339.55 | 3,090,670.00 | https://www.sec.gov/Archives/edgar/data/1576263/000089924320030059/0000899243-20-030059-index.htm |
| 2020-10-28 | Ltd. Braslyn | 10% Share Holder | Sell | 44,959.00 | 203.35 | 9,142,322.73 | 3,091,007.00 | https://www.sec.gov/Archives/edgar/data/1576263/000089924320030059/0000899243-20-030059-index.htm |
| 2020-10-29 | Ltd. Braslyn | 10% Share Holder | Sell | 10,599.00 | 210.58 | 2,231,944.84 | 3,105,078.00 | https://www.sec.gov/Archives/edgar/data/1576263/000089924320030059/0000899243-20-030059-index.htm |
| 2020-10-29 | Ltd. Braslyn | 10% Share Holder | Sell | 15,091.00 | 209.66 | 3,163,970.01 | 3,115,677.00 | https://www.sec.gov/Archives/edgar/data/1576263/000089924320030059/0000899243-20-030059-index.htm |
| 2020-10-29 | Ltd. Braslyn | 10% Share Holder | Sell | 1,674.00 | 208.78 | 349,497.89 | 3,130,768.00 | https://www.sec.gov/Archives/edgar/data/1576263/000089924320030059/0000899243-20-030059-index.htm |
| 2020-10-29 | Ltd. Braslyn | 10% Share Holder | Sell | 1,086.00 | 207.96 | 225,849.23 | 3,132,442.00 | https://www.sec.gov/Archives/edgar/data/1576263/000089924320030059/0000899243-20-030059-index.htm |
| 2020-10-29 | Ltd. Braslyn | 10% Share Holder | Sell | 1,088.00 | 206.50 | 224,670.91 | 3,133,528.00 | https://www.sec.gov/Archives/edgar/data/1576263/000089924320030059/0000899243-20-030059-index.htm |
| 2020-10-29 | Ltd. Braslyn | 10% Share Holder | Sell | 800.00 | 205.64 | 164,515.84 | 3,134,616.00 | https://www.sec.gov/Archives/edgar/data/1576263/000089924320030059/0000899243-20-030059-index.htm |
| 2020-10-29 | Ltd. Braslyn | 10% Share Holder | Sell | 550.00 | 203.32 | 111,827.54 | 3,135,416.00 | https://www.sec.gov/Archives/edgar/data/1576263/000089924320030059/0000899243-20-030059-index.htm |
| 2020-10-29 | Ltd. Braslyn | 10% Share Holder | Buy | 104,565.00 | 0.00 | 104.57 | 3,135,967.00 | https://www.sec.gov/Archives/edgar/data/1576263/000089924320030059/0000899243-20-030059-index.htm |
| 2020-10-28 | Ltd. Braslyn | 10% Share Holder | Buy | 295,438.00 | 0.00 | 295.44 | 3,135,968.00 | https://www.sec.gov/Archives/edgar/data/1576263/000089924320030059/0000899243-20-030059-index.htm |
| 2019-03-01 | Ltd. Braslyn | 10% Share Holder | Buy | 275,004.00 | 0.00 | 275.00 | 3,135,970.00 | https://www.sec.gov/Archives/edgar/data/1576263/000089924319006351/0000899243-19-006351-index.htm |
| 2020-06-12 | Ltd. Braslyn | 10% Share Holder | Buy | 600,006.00 | 0.00 | 600.01 | 3,135,972.00 | https://www.sec.gov/Archives/edgar/data/1576263/000089924320016664/0000899243-20-016664-index.htm |
| 2020-03-26 | Jamie Christensen | EVP, Chief Scientific Officer | Buy | 888.00 | 17.41 | 15,460.08 | 31,592.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465920002971/0001214659-20-002971-index.htm |
| 2020-03-26 | Jamie Christensen | EVP, Chief Scientific Officer | Buy | 1,250.00 | 21.51 | 26,887.50 | 32,842.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465920002971/0001214659-20-002971-index.htm |
| 2019-01-23 | ISAN CHEN | EVP, Chief Medical Officer | Buy | 244.00 | 24.99 | 6,097.56 | 35,210.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919000538/0001214659-19-000538-index.htm |
| 2019-01-23 | ISAN CHEN | EVP, Chief Medical Officer | Buy | 625.00 | 21.51 | 13,443.75 | 35,835.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919000538/0001214659-19-000538-index.htm |
| 2019-01-23 | ISAN CHEN | EVP, Chief Medical Officer | Buy | 1.00 | 5.40 | 5.40 | 35,836.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919000538/0001214659-19-000538-index.htm |
| 2020-05-21 | Jamie Christensen | EVP, Chief Scientific Officer | Buy | 5,000.00 | 37,842.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465920004964/0001214659-20-004964-index.htm | ||
| 2019-07-23 | Avoro Capital Advisors LLC | 10% Share Holder | Sell | 62,500.00 | 101.88 | 6,367,500.00 | 3,800,000.00 | https://www.sec.gov/Archives/edgar/data/1576263/000090266419003156/0000902664-19-003156-index.htm |
| 2019-08-12 | MICHAEL G GREY | Director | Sell | 1,032.00 | 91.20 | 94,118.71 | 3,808.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919005304/0001214659-19-005304-index.htm |
| 2019-03-20 | venBio Select Advisor LLC | 10% Share Holder | Sell | 23,781.00 | 72.80 | 1,731,256.80 | 3,862,500.00 | https://www.sec.gov/Archives/edgar/data/1576263/000090266419001604/0000902664-19-001604-index.htm |
| 2019-03-19 | venBio Select Advisor LLC | 10% Share Holder | Sell | 100,000.00 | 73.43 | 7,343,000.00 | 3,886,281.00 | https://www.sec.gov/Archives/edgar/data/1576263/000090266419001604/0000902664-19-001604-index.htm |
| 2020-01-03 | Aaron I. Davis | Director | Buy | 2,000.00 | 39,052.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465920000194/0001214659-20-000194-index.htm | ||
| 2020-01-29 | ISAN CHEN | EVP, Chief Medical Officer | Buy | 3,002.00 | 24.99 | 75,019.98 | 39,401.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465920000769/0001214659-20-000769-index.htm |
| 2020-05-11 | ISAN CHEN | EVP, Chief Medical Officer | Sell | 33,334.00 | 105.00 | 3,500,070.00 | 39,401.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465920004484/0001214659-20-004484-index.htm |
| 2020-11-02 | Jamie Christensen | EVP, Chief Scientific Officer | Buy | 1,595.00 | 24.99 | 39,859.05 | 39,437.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465920009173/0001214659-20-009173-index.htm |
| 2019-03-18 | venBio Select Advisor LLC | 10% Share Holder | Sell | 125,000.00 | 76.55 | 9,568,750.00 | 3,986,281.00 | https://www.sec.gov/Archives/edgar/data/1576263/000090266419001604/0000902664-19-001604-index.htm |
| 2019-02-20 | venBio Select Advisor LLC | 10% Share Holder | Sell | 686,820.00 | 73.00 | 50,137,860.00 | 4,111,281.00 | https://www.sec.gov/Archives/edgar/data/1576263/000090266419001248/0000902664-19-001248-index.htm |
| 2020-08-11 | BRUCE L A CARTER | Director | Buy | 2,250.00 | 6.78 | 15,255.00 | 4,250.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465920007045/0001214659-20-007045-index.htm |
| 2020-01-03 | MICHAEL G GREY | Director | Buy | 2,000.00 | 4,256.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465920000192/0001214659-20-000192-index.htm | ||
| 2020-11-02 | Jamie Christensen | EVP, Chief Scientific Officer | Buy | 5,000.00 | 5.50 | 27,500.00 | 44,437.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465920009173/0001214659-20-009173-index.htm |
| 2019-08-12 | MICHAEL G GREY | Director | Buy | 3,500.00 | 16.84 | 58,940.00 | 4,840.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919005304/0001214659-19-005304-index.htm |
| 2020-11-02 | Jamie Christensen | EVP, Chief Scientific Officer | Buy | 4,284.00 | 5.40 | 23,133.60 | 48,721.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465920009173/0001214659-20-009173-index.htm |
| 2019-11-12 | MICHAEL G GREY | Director | Buy | 3,500.00 | 16.84 | 58,940.00 | 5,298.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919007223/0001214659-19-007223-index.htm |
| 2019-12-24 | CHARLES M BAUM | President & CEO | Buy | 1.00 | 5.40 | 5.40 | 56,600.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919008006/0001214659-19-008006-index.htm |
| 2019-12-24 | CHARLES M BAUM | President & CEO | Buy | 317.00 | 24.99 | 7,921.83 | 56,917.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919008006/0001214659-19-008006-index.htm |
| 2020-05-18 | BRUCE L A CARTER | Director | Buy | 4,000.00 | 6.78 | 27,120.00 | 6,000.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465920004864/0001214659-20-004864-index.htm |
| 2019-02-14 | CHRISTOPHER C. LEMASTERS | EVP, Chief Business Officer | Buy | 60,000.00 | 6.45 | 387,000.00 | 60,000.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919001353/0001214659-19-001353-index.htm |
| 2019-02-21 | CHARLES M BAUM | President & CEO | Buy | 79.00 | 24.99 | 1,974.21 | 62,497.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919001486/0001214659-19-001486-index.htm |
| 2019-02-21 | CHARLES M BAUM | President & CEO | Buy | 2.00 | 5.40 | 10.80 | 62,499.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919001486/0001214659-19-001486-index.htm |
| 2019-02-21 | CHARLES M BAUM | President & CEO | Buy | 3,542.00 | 21.51 | 76,188.42 | 66,041.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919001486/0001214659-19-001486-index.htm |
| 2019-02-25 | CHARLES M BAUM | President & CEO | Sell | 100.00 | 79.09 | 7,909.00 | 66,041.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919001618/0001214659-19-001618-index.htm |
| 2019-08-22 | CHARLES M BAUM | President & CEO | Sell | 1,736.00 | 91.12 | 158,176.68 | 66,041.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919005436/0001214659-19-005436-index.htm |
| 2019-08-22 | CHARLES M BAUM | President & CEO | Buy | 2.00 | 5.40 | 10.80 | 66,043.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919005436/0001214659-19-005436-index.htm |
| 2019-02-25 | CHARLES M BAUM | President & CEO | Sell | 2,066.00 | 77.96 | 161,063.91 | 66,141.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919001618/0001214659-19-001618-index.htm |
| 2019-08-22 | CHARLES M BAUM | President & CEO | Buy | 556.00 | 24.99 | 13,894.44 | 66,599.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919005436/0001214659-19-005436-index.htm |
| 2019-08-22 | CHARLES M BAUM | President & CEO | Sell | 1,622.00 | 89.24 | 144,752.79 | 67,777.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919005436/0001214659-19-005436-index.htm |
| 2019-02-25 | CHARLES M BAUM | President & CEO | Sell | 5,687.00 | 76.75 | 436,502.84 | 68,207.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919001618/0001214659-19-001618-index.htm |
| 2019-08-22 | CHARLES M BAUM | President & CEO | Sell | 4,544.00 | 88.24 | 400,967.10 | 69,399.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919005436/0001214659-19-005436-index.htm |
| 2019-01-29 | Craig A Johnson | Director | Buy | 7,000.00 | 15.79 | 110,530.00 | 7,000.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919000676/0001214659-19-000676-index.htm |
| 2019-05-13 | MICHAEL G GREY | Director | Buy | 7,100.00 | 16.84 | 119,564.00 | 7,100.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919003616/0001214659-19-003616-index.htm |
| 2020-05-11 | ISAN CHEN | EVP, Chief Medical Officer | Buy | 33,334.00 | 24.99 | 833,016.66 | 72,735.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465920004484/0001214659-20-004484-index.htm |
| 2019-02-25 | CHARLES M BAUM | President & CEO | Sell | 18,235.00 | 75.77 | 1,381,642.24 | 73,894.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919001618/0001214659-19-001618-index.htm |
| 2019-08-22 | CHARLES M BAUM | President & CEO | Sell | 3,619.00 | 86.58 | 313,325.78 | 73,943.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919005436/0001214659-19-005436-index.htm |
| 2019-02-15 | Jamie A Donadio | Sr. VP, CFO | Buy | 7,500.00 | 5.40 | 40,500.00 | 7,721.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919001354/0001214659-19-001354-index.htm |
| 2019-05-16 | Jamie A Donadio | Sr. VP, CFO | Buy | 7,500.00 | 5.50 | 41,250.00 | 7,721.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919003693/0001214659-19-003693-index.htm |
| 2019-08-22 | CHARLES M BAUM | President & CEO | Sell | 28,446.00 | 85.89 | 2,443,093.24 | 77,562.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919005436/0001214659-19-005436-index.htm |
| 2020-01-06 | VICKIE S REED | SVP, Chief Accounting Officer | Buy | 2,750.00 | 8,250.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465920000360/0001214659-20-000360-index.htm | ||
| 2020-08-10 | HENRY J FUCHS | Director | Sell | 1,300.00 | 131.08 | 170,407.51 | 8,300.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465920006974/0001214659-20-006974-index.htm |
| 2019-01-29 | Craig A Johnson | Director | Sell | 8,475.00 | 61.11 | 517,941.15 | 8,525.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919000676/0001214659-19-000676-index.htm |
| 2019-12-23 | Jamie Christensen | EVP, Chief Scientific Officer | Sell | 2,499.00 | 125.00 | 312,375.00 | 9,159.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919008005/0001214659-19-008005-index.htm |
| 2019-02-25 | CHARLES M BAUM | President & CEO | Sell | 25,722.00 | 75.17 | 1,933,553.61 | 92,129.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465919001618/0001214659-19-001618-index.htm |
| 2020-08-10 | HENRY J FUCHS | Director | Sell | 1,000.00 | 129.80 | 129,803.00 | 9,600.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465920006974/0001214659-20-006974-index.htm |
| 2020-01-03 | CHARLES M BAUM | President & CEO | Buy | 40,000.00 | 97,197.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465920000199/0001214659-20-000199-index.htm | ||
| 2019-07-17 | Boxer Capital, LLC | 10% Share Holder | Sell | 725,000.00 | 98.30 | 71,267,500.00 | 990,560.00 | https://www.sec.gov/Archives/edgar/data/1576263/000089924319019989/0000899243-19-019989-index.htm |
| 2020-02-04 | CHARLES M BAUM | President & CEO | Buy | 2,291.00 | 5.40 | 12,371.40 | 99,488.00 | https://www.sec.gov/Archives/edgar/data/1576263/000121465920001004/0001214659-20-001004-index.htm |